Our research team assigns Bronze ratings to strategies they’re confident will outperform a relevant index, or most peers, over a market cycle on a risk-adjusted basis. Managers Dan LeVan and ...
Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to protect against multiple norovirus genotypes. Moderna provided an update on the status of its trial investigating a ...
Background Because inactivated trivalent influenza vaccines (TIVs) contain 1 influenza B strain, whereas 2 lineages may co-circulate, B lineage mismatch is frequent. We assessed an inactivated ...
The Fund seeks long-term growth of capital. The Fund invests at least 80% of its assets in securities of small- to mid-capitalization companies.
Changes to both schedules include new and updated recommendations for COVID-19 vaccine, change to trivalent influenza vaccines ...
Our research team assigns Neutral ratings to strategies they’re not confident will outperform a relevant index, or most peers, over a market cycle on a risk-adjusted basis. Managers Dan LeVan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback